Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coxsackievirus A24 Causing Acute Conjunctivitis in a 2023 outbreak in Vietnam.
Tran H, Ha T, Hoang L, Tran Y, Ruder K, Zhong L, Chen C, Liu Y, Yu D, Abraham T, Hinterwirth A, Deiner M, Porco TC, Lietman TM, Doan T, Seitzman GD; SCORPIO Study Group. Tran H, et al. Among authors: abraham t. Int J Infect Dis. 2024 Jun 12:107133. doi: 10.1016/j.ijid.2024.107133. Online ahead of print. Int J Infect Dis. 2024. PMID: 38876162
Pathogen Profiles of Infectious Conjunctivitis in Ho Chi Minh City, Vietnam.
Tran H, Hoang L, Tran Y, Hạ T, Ruder K, Zhong L, Chen C, Yu D, Liu Y, Abraham T, Hinterwirth A, Deiner M, Porco T, Lietman TM, Seitzman GD, Doan T. Tran H, et al. Among authors: abraham t. Cornea Open. 2023 Dec;2(4):e0025. doi: 10.1097/coa.0000000000000025. Epub 2023 Dec 7. Cornea Open. 2023. PMID: 38855500 Free PMC article.
Human Conjunctival Transcriptome in Acanthamoeba Keratitis: An Exploratory Study.
Seitzman GD, Keenan JD, Lietman TM, Ruder K, Zhong L, Chen C, Liu Y, Yu D, Abraham T, Hinterwirth A, Doan T; capriCORN (Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory markers in the CORNea) Study Group. Seitzman GD, et al. Among authors: abraham t. Cornea. 2024 May 21. doi: 10.1097/ICO.0000000000003545. Online ahead of print. Cornea. 2024. PMID: 38771726
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Maron MS, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Coats CJ, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Abraham TP; SEQUOIA-HCM Investigators. Maron MS, et al. Among authors: abraham tp. N Engl J Med. 2024 May 30;390(20):1849-1861. doi: 10.1056/NEJMoa2401424. Epub 2024 May 13. N Engl J Med. 2024. PMID: 38739079 Clinical Trial.
Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
Maron MS, Mahmod M, Abd Samat AH, Choudhury L, Massera D, Phelan DMJ, Cresci S, Martinez MW, Masri A, Abraham TP, Adler E, Wever-Pinzon O, Nagueh SF, Lewis GD, Chamberlin P, Patel J, Yavari A, Dehbi HM, Sarwar R, Raman B, Valkovič L, Neubauer S, Udelson JE, Watkins H. Maron MS, et al. Among authors: abraham tp. J Am Coll Cardiol. 2024 May 28;83(21):2037-2048. doi: 10.1016/j.jacc.2024.03.387. Epub 2024 Apr 8. J Am Coll Cardiol. 2024. PMID: 38599256 Free article. Clinical Trial.
646 results